Figure 5From: Levosimendan limits reperfusion injury in a rat middle cerebral artery occlusion (MCAO) model Additional effects of levosimendan treatment on neurological injury during MCAO. Differences between groups for brain swelling (A), serum levels of s-100ß (B) and neurological testing (C) after 24 hours were displayed (* p <0.05 vs. control; ** p < 0.01 vs. control).Back to article page